Company Arch Biopartners Inc. Toronto S.E.
Equities
ARCH
CA03938C1041
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 CAD | +1.85% |
|
-1.79% | +11.49% |
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Technologies
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +105.63% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 1 | 100.0 % | 2 | 100.0 % | +105.63% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Daniel Muruve
FOU | Founder | - | 04/83/04 |
Richard Muruve
FOU | Founder | - | 04/83/04 |
Andrew Bishop
DFI | Director of Finance/CFO | 58 | 01/10/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Rossman
BRD | Director/Board Member | - | 07/10/07 |
Richard Muruve
FOU | Founder | - | 04/83/04 |
Claude Allary
BRD | Director/Board Member | 69 | 01/14/01 |
Andrew Bishop
DFI | Director of Finance/CFO | 58 | 01/10/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 63,850,633 | 51,265,123 ( 80.29 %) | 0 | 80.29 % |
Company contact information
![address Arch Biopartners Inc.(ARCH)](https://cdn.zonebourse.com/static/address/49478405.png)
Sector
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.36% | 5.25TCr | |
+36.73% | 3.93TCr | |
-8.63% | 3.9TCr | |
+25.46% | 2.82TCr | |
-11.17% | 2.66TCr | |
+11.44% | 2.62TCr | |
+45.09% | 1.42TCr | |
+32.93% | 1.26TCr | |
-5.30% | 1.17TCr |
- Stock Market
- Equities
- ACHFF Stock
- ARCH Stock
- Company Arch Biopartners Inc.